Can-Fite BioPharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CANF and other ETFs, options, and stocks.About CANF
Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602.
CEOMotti Farbstein
CEOMotti Farbstein
Employees5
Employees5
HeadquartersRamat Gan, HaMerkaz
HeadquartersRamat Gan, HaMerkaz
Founded1994
Founded1994
Employees5
Employees5
CANF Key Statistics
Market cap5.69M
Market cap5.69M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume76.62K
Average volume76.62K
High today$4.41
High today$4.41
Low today$4.22
Low today$4.22
Open price$4.31
Open price$4.31
Volume8.03K
Volume8.03K
52 Week high$46.60
52 Week high$46.60
52 Week low$3.36
52 Week low$3.36
CANF News
TipRanks 4d
Can-Fite BioPharma Wins Canadian Patent Allowance for Namodenoson Obesity UseThe latest update is out from Can-Fite BioPharma ( (CANF) ). On February 9, 2026, Can-Fite BioPharma announced that the Canadian Patent Office issued a notice...
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.